Lockman Alee, Callaghan Timothy, Blackburn Christine Crudo, Colwell Brian
Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station, TX, United States.
Department of Health Law, Policy, and Management, School of Public Health, Boston University, Boston, MA, United States.
Vaccine. 2025 Jan 1;43(Pt 2):126528. doi: 10.1016/j.vaccine.2024.126528. Epub 2024 Nov 12.
Vaccine hesitancy and a distrust of the COVID-19 vaccine is widespread in many African nations, stemming from historic medical abuses and low confidence in governments. While studies have examined drivers of vaccine hesitancy in Africa, little is known about vaccine spillover effects: how prior experiences with vaccines influence individuals' confidence in vaccines and future vaccination behaviors.
In a large online survey conducted across three African countries (Kenya, N = 1545; Nigeria, N = 1557; South Africa, N = 1588), we examined five measures of vaccine spillover: how experiences with the COVID-19 vaccination process influenced respondents' confidence in the safety, efficacy, and importance of all vaccines approved for use in their country, and the likelihood of vaccinating themselves or their children in the future. Multivariate binary logistic regression analyses were conducted to determine factors associated with each of the five outcome measures.
Large numbers of individuals in all three countries experienced positive vaccine spillover: becoming more likely to vaccinate in the future and experiencing greater confidence in vaccines, due to their prior experiences with the COVID-19 vaccination process. The highest positive spillover effects were observed in Kenya, with 71 % reporting a greater likelihood of vaccinating themselves in the future, compared to just 60.1 % of Nigerian respondents and 51.7 % of South African respondents. Multivariate models provide evidence that demographic correlates of positive vaccine spillover vary across nations; however, prior vaccination, misinformation endorsement, and confidence in government both consistently predict spillover in all three nations.
These findings suggest that while drivers of vaccine spillover are country specific, strategies to address COVID-19 misinformation and to strengthen individuals' trust in government may help facilitate greater vaccine uptake in the future.
疫苗犹豫以及对新冠疫苗的不信任在许多非洲国家普遍存在,这源于历史上的医疗滥用行为以及对政府的信心不足。虽然已有研究探讨了非洲疫苗犹豫的驱动因素,但对于疫苗的溢出效应却知之甚少,即疫苗接种的既往经历如何影响个体对疫苗的信心以及未来的接种行为。
在对三个非洲国家(肯尼亚,N = 1545;尼日利亚,N = 1557;南非,N = 1588)进行的一项大型在线调查中,我们考察了疫苗溢出效应的五个指标:新冠疫苗接种过程的经历如何影响受访者对本国批准使用的所有疫苗的安全性、有效性和重要性的信心,以及他们未来为自己或子女接种疫苗的可能性。进行多变量二元逻辑回归分析以确定与五个结果指标相关的因素。
所有三个国家都有大量个体经历了积极的疫苗溢出效应:由于他们此前的新冠疫苗接种经历,未来接种疫苗的可能性增加,并且对疫苗的信心增强。肯尼亚观察到最高的积极溢出效应,71%的受访者表示未来更有可能为自己接种疫苗,相比之下,尼日利亚受访者中这一比例为60.1%,南非受访者中为51.7%。多变量模型表明,积极疫苗溢出效应的人口统计学相关因素因国家而异;然而,既往接种、错误信息认同以及对政府的信心在所有三个国家都始终能预测溢出效应。
这些发现表明,虽然疫苗溢出效应的驱动因素因国家而异,但应对新冠错误信息以及增强个体对政府信任的策略可能有助于在未来促进更高的疫苗接种率。